Your browser doesn't support javascript.
loading
KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.
Wen, Qing; Dunne, Philip D; O'Reilly, Paul G; Li, Gerald; Bjourson, Anthony J; McArt, Darragh G; Hamilton, Peter W; Zhang, Shu-Dong.
  • Wen Q; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Dunne PD; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • O'Reilly PG; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Li G; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Bjourson AJ; Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, Ulster University, C-TRIC, Londonderry, UK.
  • McArt DG; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Hamilton PW; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
  • Zhang SD; Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK.
Oncotarget ; 8(2): 3206-3225, 2017 Jan 10.
Article en En | MEDLINE | ID: mdl-27965461
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Proteínas ras / Antagonistas de Receptores de Angiotensina / Mutación / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Proteínas ras / Antagonistas de Receptores de Angiotensina / Mutación / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article